CNBS 250516 4.00P(CNBS250516P4000) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CNBS250516P4000

Watchlist

0.00
0.000.00%

15min DelayClose May 9 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Trump's DEA Pick to Prioritize Cannabis Rescheduling Review If Confirmed
Seeking AlphaApr 30 13:56 ET
Economic Impact of U.S. Cannabis Industry Set to Double Over Next Six Years
Seeking AlphaApr 25 13:16 ET
Alcohol Retailers Want to Be in Charge of Marijuana Sales
Seeking AlphaApr 16 15:05 ET
Marijuana Rescheduling Process Remains on Hold, DEA Says
Seeking AlphaApr 11 14:43 ET
Cannabis Stocks Rise as Trump Ally Gaetz Says President Backs Rescheduling
Seeking AlphaMar 27 15:25 ET
Cannabis MSOs Rise Amid Renewed Hope for Federal Marijuana Legalization
Seeking AlphaMar 5 13:50 ET

Comments

Kevin Matte

Feb 19 11:41

Cannabis Industry's Analysis and It's Top 10 marketcap company

$Advisorshares Trust Pure Us Cannabis Etf (MSOS.US)$ Part 1: Overview of the Cannabis Industry and MSOS ETF Analysis
The cannabis industry has undergone significant changes in recent years, influenced by various economic, political, and regulatory factors. The AdvisorShares Pure US Cannabis ETF (MSOS) provides an interesting perspective for analyzing these dynamics, as it focuses on U.S.-based companies operating within the cannabis s...

Trump 2.0 Era: How will global markets evolve?

Ultratech

Sep 3, 2024 04:54

$Amplify Etf Tr Seymour Cannabis Etf (CNBS.US)$

Dumb Money Space Ape

Aug 9, 2024 05:48

$Aurora Cannabis (ACB.US)$ Herb rally/squeeze incoming! Love him or not, he’s got a way of moving the markets. Trump Says He Agrees People Should Not Be Criminalized Over Marijuana As More States Legalize
$Tilray Brands (TLRY.US)$
$SNDL Inc (SNDL.US)$
$Canopy Growth (CGC.US)$
$Advisorshares Trust Pure Us Cannabis Etf (MSOS.US)$
$Amplify Etf Tr Seymour Cannabis Etf (CNBS.US)$
$Femto Technologies (BCAN.US)$

PREMOSULTRAA

Aug 31, 2023 15:33

US health officials look to move marijuana to lower-risk drug category

Important to note that it's not a surefire thing that it'll be rescheduled to III. This is just the HHS recommendation to the DEA which is binding only so far as scientific evidence for scheduling. There's still the unknown of politics that could drive the DEA to schedule it differently, such as II or even keep it in I. That said, this is a huge deal and in my opinion schedule III is more likely than not.
NEW: US health off...

BEAN8444

Jul 15, 2022 01:24

Recession

$Amplify Etf Tr Seymour Cannabis Etf (CNBS.US)$ https://www.washingtonpost.com/business/2022/07/13/fed-inflation-recession/